Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Geron Corporation, Pfizer, Under Armour and more - PRE-MARKET

Proactive keeps and eye on the share needle before the bell in New York

It looks to be a fairly busy day on the corporate front and Geron Corporation (NASDAQ:GERN) is a stock in focus before the bell.

Shares raced up over 9% to US$2.25 after the company reported that the key FDA (Food and Drug Agency) had given what's called "Fast Track" designation to the biotech's imetelstat candidate for lower risk myelodysplastic syndromes.

Sticking with pharma stocks and giant Pfizer Inc (NYSE:PFE) saw shares drop 0.23% to US$35.07 before the bell after the company reported upbeat earnings for its third quarter and raised its 2017 guidance.

Also lower was Under Armour Inc (NYSE:UA) as the company reported weaker-than-expected revenue for its third quarter lowered its 2017 forecast. Shares tanked over 17% to US$13.50 before bell on Wall Street.

Elsewhere, Plug Power Inc (NASDAQ:PLUG) rose over 8% in pre-market deals to US$2.95 as the company reported a new European deal with Asko and Toyota Material Handling.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK